Clin2
NCT07572071Possibly a fitRecruiting

Cell transplant study for moderate Parkinson's disease

Parkinson Disease (PD)

Part of Brain & nervous system clinical trials.

This trial tests whether transplanting specially grown cells (DopaCell) into the brain can safely help people with moderate Parkinson's disease whose symptoms aren't well controlled by medication. The cells are intended to produce dopamine, the chemical that Parkinson's affects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
6 people
Ages
30 years to 70 years
Study type
Interventional

Who can take part

  • You are between 30 and 70 years old
  • You have been diagnosed with Parkinson's disease for at least 5 years
  • Your Parkinson's is at a moderate stage, and your symptoms don't improve enough with current medications
  • Your body responds well to levodopa (a standard Parkinson's medication), as confirmed by your doctor
  • You have no major brain injuries or abnormalities on MRI scans
  • Your blood counts, liver, and kidney function are within acceptable ranges

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07028632Not yet recruiting· Phase 2
Cell therapy for Parkinson's disease: NouvNeu001 trial

This trial tests a new cell therapy, NouvNeu001, for people with Parkinson's disease who have had symptoms for at least 4 years and are having trouble with their current medications. The goal is to see if this treatment is safe and can improve motor symptoms that are not well controlled.

Beijing, Beijing Municipality
NCT07232147Not yet recruiting· Phase 1
Stem cell therapy trial for Parkinson's disease

This trial tests a new stem cell treatment for people with Parkinson's disease. It's for those whose symptoms affect daily life and who still respond to levodopa but find it less effective over time.

NCT06858254Not yet recruiting· Phase 1/Phase 2
Stem cell optimization for Parkinson's and related conditions

This trial tests a stem cell treatment to see if it can improve symptoms in people with Parkinson's disease or other similar conditions, like dementia with Lewy bodies or multiple system atrophy. It involves an injection of stem cells harvested from your own bone marrow.

NCT06482268Recruiting· Phase 1
Cell transplant for advanced parkinson's disease

This trial tests a new type of cell transplant for Parkinson's disease. The cells are made from stem cells and are meant to replace damaged brain cells that produce dopamine, which may improve your motor symptoms.

La Jolla, California
NCT07102342Recruiting· Phase 1/Phase 2
Cell therapy for Parkinson's disease

This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.

New York, New York
NCT06687837Recruiting· Phase 1
Stem cell therapy for Parkinson's disease

This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.

Boston, Massachusetts

Hear when a new Parkinson Disease (PD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.